John Hussman's ASND Position Overview
John Hussman (via Hussman Strategic Advisors, Inc.) currently holds 8,400 shares of Ascendis Pharma A/S (ASND) worth $1.92 M, representing 0.42% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, John Hussman has initiated a new position in ASND, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
John Hussman's Ascendis Pharma A/S (ASND) Holding Value Over Time
Track share changes against reported price movement
Quarterly Ascendis Pharma A/S (ASND) Trades by John Hussman
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +8,400 | New Buy | 8,400 | $228.73 |
John Hussman's Ascendis Pharma A/S Investment FAQs
John Hussman first purchased Ascendis Pharma A/S (ASND) in Q1 2026, acquiring 8,400 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Hussman has held Ascendis Pharma A/S (ASND) for 1 quarters since Q1 2026.
John Hussman's largest addition to Ascendis Pharma A/S (ASND) was in Q1 2026, adding 8,400 shares worth $1.92 M.
According to the latest 13F filing for Q1 2026, John Hussman's firm, Hussman Strategic Advisors, Inc., owns 8,400 shares of Ascendis Pharma A/S (ASND), valued at approximately $1.92 M.
As of the Q1 2026 filing, Ascendis Pharma A/S (ASND) represents approximately 0.42% of John Hussman's publicly disclosed stock portfolio, making it one of their key holdings.
John Hussman's peak holding in Ascendis Pharma A/S (ASND) was 8,400 shares, as reported at the end of Q1 2026.